Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 8704221)

1.

Clinical applications of gene therapy for primary immunodeficiencies.

Cicalese MP, Aiuti A.

Hum Gene Ther. 2015 Apr;26(4):210-9. doi: 10.1089/hum.2015.047.

PMID:
25860576
2.

Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.

Panch SR, Yau YY, Kang EM, De Ravin SS, Malech HL, Leitman SF.

Transfusion. 2015 Feb;55(2):265-74. doi: 10.1111/trf.12830. Epub 2014 Aug 21.

PMID:
25143186
3.

Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment.

Ludin A, Gur-Cohen S, Golan K, Kaufmann KB, Itkin T, Medaglia C, Lu XJ, Ledergor G, Kollet O, Lapidot T.

Antioxid Redox Signal. 2014 Oct 10;21(11):1605-19. doi: 10.1089/ars.2014.5941. Epub 2014 Jun 26. Review.

PMID:
24762207
4.

G-CSF in Healthy Allogeneic Stem Cell Donors.

Hölig K.

Transfus Med Hemother. 2013 Aug;40(4):225-35. doi: 10.1159/000354196. Epub 2013 Jul 22. Review.

5.

Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, Pan J, Linton G, Chen L, Koontz S, Theobald NL, Malech HL.

Blood. 2013 Apr 4;121(14):e98-107. doi: 10.1182/blood-2012-03-420273. Epub 2013 Feb 5.

6.

"Special exemptions": should they be put on trial?

Gaspar HB, Swift S, Thrasher AJ.

Mol Ther. 2013 Feb;21(2):261-2. doi: 10.1038/mt.2013.1. No abstract available.

7.

The role of complement in the trafficking of hematopoietic stem/progenitor cells.

Janowska-Wieczorek A, Marquez-Curtis LA, Shirvaikar N, Ratajczak MZ.

Transfusion. 2012 Dec;52(12):2706-16. doi: 10.1111/j.1537-2995.2012.03636.x. Epub 2012 Apr 9. Review. No abstract available.

8.

The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.

Marquez-Curtis LA, Turner AR, Sridharan S, Ratajczak MZ, Janowska-Wieczorek A.

Stem Cell Rev. 2011 Sep;7(3):590-607. doi: 10.1007/s12015-010-9212-8. Review.

9.

Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells.

Jalili A, Shirvaikar N, Marquez-Curtis L, Qiu Y, Korol C, Lee H, Turner AR, Ratajczak MZ, Janowska-Wieczorek A.

Exp Hematol. 2010 Apr;38(4):321-32. doi: 10.1016/j.exphem.2010.02.002. Epub 2010 Feb 12.

10.

Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes.

Lee HM, Wysoczynski M, Liu R, Shin DM, Kucia M, Botto M, Ratajczak J, Ratajczak MZ.

Leukemia. 2010 Mar;24(3):573-82. doi: 10.1038/leu.2009.271. Epub 2009 Dec 24.

11.

Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function.

Ushio-Fukai M, Urao N.

Antioxid Redox Signal. 2009 Oct;11(10):2517-33. doi: 10.1089/ARS.2009.2582. Review.

12.

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman RD, Van Epps DE, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12133-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk